Search by Drug Name or NDC

    NDC 00078-0246-15 Neoral 25 mg/1 Details

    Neoral 25 mg/1

    Neoral is a ORAL CAPSULE, LIQUID FILLED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is CYCLOSPORINE.

    Product Information

    NDC 00078-0246
    Product ID 0078-0246_2bc01154-2f23-4d1f-97c5-c83086800c76
    Associated GPIs 99402020300120
    GCN Sequence Number 023882
    GCN Sequence Number Description cyclosporine, modified CAPSULE 25 MG ORAL
    HIC3 Z2E
    HIC3 Description IMMUNOSUPPRESSIVES
    GCN 13918
    HICL Sequence Number 010086
    HICL Sequence Number Description CYCLOSPORINE, MODIFIED
    Brand/Generic Brand
    Proprietary Name Neoral
    Proprietary Name Suffix n/a
    Non-Proprietary Name cyclosporine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE, LIQUID FILLED
    Route ORAL
    Active Ingredient Strength 25
    Active Ingredient Units mg/1
    Substance Name CYCLOSPORINE
    Labeler Name Novartis Pharmaceuticals Corporation
    Pharmaceutical Class Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA050715
    Listing Certified Through 2025-12-31

    Package

    NDC 00078-0246-15 (00078024615)

    NDC Package Code 0078-0246-15
    Billing NDC 00078024615
    Package 30 BLISTER PACK in 1 CARTON (0078-0246-15) / 1 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (0078-0246-61)
    Marketing Start Date 1995-07-14
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 2.58432
    Pricing Unit EA
    Effective Date 2024-01-10
    NDC Description NEORAL 25 MG GELATIN CAPSULE
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 4
    Classification for Rate Setting B
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis